CD22

CD22 molecule
Identifiers
Symbols CD22; FLJ22814; MGC130020; SIGLEC-2; SIGLEC2
External IDs OMIM107266 MGI88322 HomoloGene31052 GeneCards: CD22 Gene
RNA expression pattern
More reference expression data
Orthologs
Species Human Mouse
Entrez 933 12483
Ensembl ENSG00000012124 ENSMUSG00000030577
UniProt P20273 Q3T9T5
RefSeq (mRNA) NM_001185099.1 NM_001043317
RefSeq (protein) NP_001172028.1 NP_001036782
Location (UCSC) Chr 19:
35.82 – 35.84 Mb
Chr 7:
31.65 – 31.67 Mb
PubMed search [1] [2]

CD22 or cluster of differentiation-22, is a molecule belonging to the SIGLEC family of lectins.[1] It is found on the surface of mature B cells and to a lesser extent on some immature B cells. Generally speaking, CD22 is a regulatory molecule that prevents the overactivation of the immune system and the development of autoimmune diseases.[2]

CD22 is a sugar binding transmembrane protein, which specifically binds sialic acid with an immunoglobulin (Ig) domain located at its N-terminus. The presence of Ig domains makes CD22 a member of the immunoglobulin superfamily. CD22 functions as an inhibitory receptor for B cell receptor (BCR) signalling.

An immunotoxin, BL22, that targets this receptor is being tested at the NIH.[3]

External links

Interactions

CD22 has been shown to interact with Grb2,[4][5] PTPN6,[6][5][7][8][9] LYN,[4][7] SHC1[4] and INPP5D.[4]

References

  1. ^ Crocker et al.; Clark, EA; Filbin, M; Gordon, S; Jones, Y; Kehrl, JH; Kelm, S; Le Douarin, N et al. (1998). "Siglecs: a family of sialic-acid binding lectins". Glycobiology 8 (2): v. doi:10.1093/glycob/8.2.0. PMID 9498912. 
  2. ^ Hatta et al. (1999). "Identification of the gene variations in human CD22". http://www.springerlink.com/content/cm72mmgn8npfpl00/. 
  3. ^ "BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia". ClinicalTrials.gov - U.S. National Institutes of Health. http://clinicaltrials.gov/ct/show/NCT00074048. Retrieved 2008-02-19. 
  4. ^ a b c d Poe, J C; Fujimoto M, Jansen P J, Miller A S, Tedder T F (Jun. 2000). "CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux". J. Biol. Chem. (UNITED STATES) 275 (23): 17420–7. doi:10.1074/jbc.M001892200. ISSN 0021-9258. PMID 10748054. 
  5. ^ a b Otipoby, K L; Draves K E, Clark E A (Nov. 2001). "CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1". J. Biol. Chem. (United States) 276 (47): 44315–22. doi:10.1074/jbc.M105446200. ISSN 0021-9258. PMID 11551923. 
  6. ^ Blasioli, J; Paust S, Thomas M L (Jan. 1999). "Definition of the sites of interaction between the protein tyrosine phosphatase SHP-1 and CD22". J. Biol. Chem. (UNITED STATES) 274 (4): 2303–7. doi:10.1074/jbc.274.4.2303. ISSN 0021-9258. PMID 9890995. 
  7. ^ a b Greer, S F; Justement L B (May. 1999). "CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1". J. Immunol. (UNITED STATES) 162 (9): 5278–86. ISSN 0022-1767. PMID 10228003. 
  8. ^ Law, C L; Sidorenko S P, Chandran K A, Zhao Z, Shen S H, Fischer E H, Clark E A (Feb. 1996). "CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation". J. Exp. Med. (UNITED STATES) 183 (2): 547–60. doi:10.1084/jem.183.2.547. ISSN 0022-1007. PMC 2192439. PMID 8627166. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2192439. 
  9. ^ Adachi, T; Wienands J, Wakabayashi C, Yakura H, Reth M, Tsubata T (Jul. 2001). "SHP-1 requires inhibitory co-receptors to down-modulate B cell antigen receptor-mediated phosphorylation of cellular substrates". J. Biol. Chem. (United States) 276 (28): 26648–55. doi:10.1074/jbc.M100997200. ISSN 0021-9258. PMID 11356834.